Sanders Capital, LLC holds a focused book of 44 stocks worth $83.9B as of Q1 2026 (disclosed May 14, 2026, a ~45-day 13F lag). This quarter they opened AstraZeneca PLC and trimmed Taiwan Semiconductor-SP ADR. Their largest long position is Taiwan Semiconductor-SP ADR at 11% of the equity book.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1508097/holdings"
Use Arkolith to show Sanders Capital, LLC's latest holdings, largest changes, and filing provenance.
Top-heavy: focused book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
97% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Taiwan Semiconductor Manufac SPONSORED ADS | $9.5B | 28.06M | 11.3% | ▼−12% Reduced · −3.9M sh | |
| 2 | Alphabet Inc CAP STK CL C | $8.2B | 28.73M | 9.8% | ▼−10.0% Reduced · −3.2M sh | |
| 3 | Amazon Com Inc COM | $6.2B | 29.82M | 7.4% | ▲+100% Added · +14.9M sh | |
| 4 | Meta Platforms Inc CL A | $6.0B | 10.56M | 7.2% | ▲+5.2% Added · +527K sh | |
| 5 | Seagate Technology HLDNGS PL ORD SHS | $5.1B | 12.90M | 6.0% | ▼−25% Reduced · −4.3M sh | |
| 6 | Microsoft Corp COM | $4.6B | 12.39M | 5.5% | ▲+2.0% Added · +243K sh | |
| 7 | Hca Healthcare Inc COM | $4.2B | 8.96M | 5.1% | ▼−14% Reduced · −1.5M sh | |
| 8 | Apple Inc COM | $2.8B | 10.87M | 3.3% | ▼−0.4% Reduced · −41K sh | |
| 9 | The Cigna Group COM | $2.7B | 10.29M | 3.3% | ▲+32% Added · +2.5M sh | |
| 10 | Accenture PLC Ireland SHS CLASS A | $2.2B | 11.20M | 2.6% | ▲+2.1% Added · +234K sh | |
| 11 | Bank America Corp COM | $2.2B | 45.17M | 2.6% | ▼−0.2% Reduced · −104K sh | |
| 12 | Applied Matls Inc COM | $2.1B | 6.18M | 2.5% | ▼−30% Reduced · −2.7M sh | |
| 13 | Delta Air Lines Inc COM NEW | $2.0B | 29.47M | 2.3% | ▼−0.4% Reduced · −111K sh | |
| 14 | State STR SPDR S&P 500 ETF T TR UNIT | $1.9B | 2.92M | 2.3% | ▲+43% Added · +872K sh | |
| 15 | RTX Corporation COM | $1.8B | 9.41M | 2.2% | ▲+0.1% Added · +11K sh | |
| 16 | Salesforce Inc COM | $1.8B | 9.53M | 2.1% | ▲+11% Added · +916K sh | |
| 17 | Elevance Health Inc Formerly COM | $1.7B | 5.89M | 2.1% | ▲+2.5% Added · +143K sh | |
| 18 | Unitedhealth Group Inc COM | $1.6B | 5.96M | 1.9% | ▼−0.5% Reduced · −32K sh | |
| 19 | Visa Inc COM CL A | $1.5B | 4.86M | 1.8% | ▲+47% Added · +1.5M sh | |
| 20 | United Airls Hldgs Inc COM | $1.4B | 15.20M | 1.7% | ▲+0.1% Added · +22K sh | |
| 21 | AstraZeneca PLC ORD | $1.4B | 7.07M | 1.7% | ▲New New position | |
| 22 | Northrop Grumman Corp COM | $1.3B | 1.87M | 1.5% | ▼−1.9% Reduced · −36K sh | |
| 23 | Nvidia Corporation COM | $1.2B | 7.13M | 1.5% | ▲New New position | |
| 24 | General Dynamics Corp COM | $1.2B | 3.62M | 1.5% | ▼−1.6% Reduced · −60K sh | |
| 25 | Cme Group Inc COM | $1.2B | 4.16M | 1.5% | ▼−0.4% Reduced · −16K sh | |
| 26 | Mastercard Incorporated CL A | $1.2B | 2.36M | 1.4% | ▲+52% Added · +812K sh | |
| 27 | JPMorgan Chase & Co COM | $1.1B | 3.90M | 1.4% | ▼−9.5% Reduced · −409K sh | |
| 28 | Ulta Beauty Inc COM | $997.4M | 1.91M | 1.2% | ▲+51% Added · +644K sh | |
| 29 | Procter & Gamble Co COM | $975.2M | 6.75M | 1.2% | ▼−0.3% Reduced · −24K sh | |
| 30 | PDD Holdings Inc SPONSORED ADS | $826.8M | 8.09M | 1.0% | ▼−0.3% Reduced · −21K sh | |
| 31 | Vanguard Intl Equity Index F ALLWRLD EX US | $749.5M | 9.98M | 0.9% | ▲+54% Added · +3.5M sh | |
| 32 | Lockheed Martin Corp COM | $689.6M | 1.14M | 0.8% | ▼−0.2% Reduced · −2K sh | |
| 33 | Trip Com Group Ltd ADS | $529.8M | 10.64M | 0.6% | ▲+7.6% Added · +750K sh | |
| 34 | Pepsico Inc COM | $275.4M | 1.77M | 0.3% | ▼−58% Reduced · −2.5M sh | |
| 35 | HSBC Hldgs PLC SPON ADR NEW | $231.6M | 2.81M | 0.3% | ▼−2.8% Reduced · −80K sh | |
| 36 | Abbott Laboratories COM | $115.1M | 1.12M | 0.1% | ▼−2.6% Reduced · −30K sh | |
| 37 | Abbvie Inc COM | $112.4M | 516.6K | 0.1% | ▼−2.9% Reduced · −16K sh | |
| 38 | Truist Finl Corp COM | $93.7M | 2.04M | 0.1% | ▼−3.1% Reduced · −65K sh | |
| 39 | Booking Holdings Inc COM | $50.4M | 299.5K | 0.1% | ▲+0.7% Added · +2K sh | |
| 40 | Shinhan Financial Group Co L SPN ADR RESTRD | $9.4M | 153.6K | 0.0% | ▼−2.5% Reduced · −4K sh | |
| 41 | Unilever PLC SPON ADR NEW | $5.2M | 91.5K | 0.0% | ▼−6.9% Reduced · −7K sh | |
| 42 | ING Groep N.V. SPONSORED ADR | $3.0M | 115.9K | 0.0% | ▼−9.7% Reduced · −13K sh | |
| 43 | Natwest Group PLC SPONS ADR | $2.8M | 185.1K | 0.0% | ▼−9.9% Reduced · −20K sh | |
| 44 | Synchrony Financial COM | $1.3M | 18.9K | 0.0% | ▼−4.9% Reduced · −970 sh |
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q1 2026 | Mar 31, 2026 | May 14, 2026 | 44 | $83.9B | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 13, 2026 | 44 | $86.8B | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 13, 2025 | 47 | $81.3B | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 8, 2025 | 47 | $74.5B | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 14, 2025 | 47 | $66.9B | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 13, 2025 | 46 | $68.4B | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 13, 2024 | 45 | $69.0B | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Aug 9, 2024 | 45 | $65.3B | 13F-HR |
| Q1 2024 | Mar 31, 2024 | May 10, 2024 | 42 | $59.9B | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Feb 12, 2024 | 44 | $54.1B | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Nov 9, 2023 | 44 | $47.3B | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Aug 11, 2023 | 49 | $47.9B | 13F-HR |
| Q1 2023 | Mar 31, 2023 | May 10, 2023 | 48 | $42.2B | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Feb 10, 2023 | 46 | $38.1B | 13F-HR |
| Q3 2022 | Sep 30, 2022 | Feb 17, 2023 | 42 | $36.4B | 13F-HR/A |
| Q2 2022 | Jun 30, 2022 | Aug 12, 2022 | 42 | $39.5B | 13F-HR |
| Q1 2022 | Mar 31, 2022 | Aug 24, 2022 | 44 | $46.0B | 13F-HR/A |
| Q4 2021 | Dec 31, 2021 | Aug 25, 2022 | 44 | $49.0B | 13F-HR/A |
| Q3 2021 | Sep 30, 2021 | Aug 24, 2022 | 45 | $44.1B | 13F-HR/A |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.